Schlude Christoph, Beckhove Philipp
Recent Results Cancer Res. 2011;183:97-109. doi: 10.1007/978-3-540-85772-3_5.
Immunotherapy for patients suffering from multiple myeloma is a lively and emerging field in cancer research. Immunotherapeutic approaches offer unique treatment opportunities for this, to date, mostly incurable disease. Respective basic findings and recent clinical approaches are introduced and discussed. Although several obstacles still need to be overcome, it appears that clinically efficient immunotherapies will become available for multiple myeloma patients in the future.
针对多发性骨髓瘤患者的免疫疗法是癌症研究中一个活跃且新兴的领域。免疫治疗方法为这种迄今为止大多无法治愈的疾病提供了独特的治疗机会。本文介绍并讨论了相关的基础研究结果和近期的临床方法。尽管仍需克服一些障碍，但未来似乎将为多发性骨髓瘤患者提供临床有效的免疫疗法。
